Cette séance de questions-réponses, faisant suite aux présentations nationales sur les systèmes d’information sanitaire, a mis en lumière quatre thématiques transversales : l’accès aux filles non scolarisées, le suivi des adolescentes séropositives nécessitant trois doses de vaccin HPV, la gestion des données dans les zones rurales à faible connectivité, et les conditions de la transition […]
Topic: Local Data Availability
Informations et données sanitaires pour l’action: Tanzanie
En Tanzanie, les systèmes d’information sanitaire constituent le socle de la planification et du suivi de la vaccination contre le HPV dans un pays de plus de 67 millions d’habitants et de plus de 12 000 formations sanitaires. Au niveau des établissements de santé, les outils papier restent en usage, tandis que du district vers […]
Informations et données sanitaires pour l’action: Rwanda
Au Rwanda, la gestion des données de vaccination contre le HPV a fait l’objet d’une transition complète des registres papier vers des systèmes numériques intégrés. Avant 2022, les agents de santé procédaient manuellement au décompte mensuel des enfants vaccinés avant de soumettre des données agrégées au HMIS, un processus source d’erreurs, de retards et de […]
Informations et données sanitaires pour l’action: Cameroun
Au Cameroun, le DHIS2 centralise les données de santé de près de 6 000 formations sanitaires, avec une remontée mensuelle des données des FOSA vers les niveaux district, régional et national. La présentation identifie cinq lacunes clés du système d’information : intégration limitée des registres scolaires dans la microplanification, absence de désagrégation par cohorte d’âge […]
Efficacy Of Quadrivalent Human Papillomavirus Vaccine Among Kenyan Adolescents And Young Adults Living With HIV Nine Years After Initial Vaccination
In Kenya, a nine-year follow-up of a cohort of 180 adolescents living with HIV who received three doses of the quadrivalent HPV vaccine at ages 9–14 found sustained vaccine-specific protection, with zero persistent infections detected for HPV types 11, 16, or 18 among 151 evaluable participants. Only two participants (1.3%) had any vaccine-genotype persistent infection, […]
Prevalence of Human Papillomavirus Type 16/18 Among Females Living in an Urban Area of the Democratic Republic of Congo
In the Democratic Republic of the Congo, a cross-sectional study of 2,000 girls and women aged 9–50 years across 18 urban quarters of Goma city found overall HPV prevalence (any of 28 genotypes) of 25.3% in the 9–14 age group, rising to 55.0% among 21–30-year-olds, with high-risk type prevalence reaching 44.2% in that same group. […]
Overcoming Barriers To Human Papillomavirus Vaccine Uptake In Sierra Leone: Insights From Formative Research In Four Low-Performing Districts
In Sierra Leone, HPV vaccination coverage fell sharply from over 100% in 2022 to 31.3% in 2023, prompting CHAI and the Ministry of Health EPI programme to conduct formative research across the four lowest-performing districts — Bonthe, Koinadugu, Kenema, and Western Area Rural. A mixed-methods study combining facility data audits and semi-structured interviews with healthcare […]
Using Routine Human Papillomavirus Vaccination Data to Guide High-Impact Community Outreach in Nigeria
In Nigeria, routine HPV vaccination coverage among nine-year-old girls remains low in Kano State, constrained by limited awareness, persistent myths, and geographic and economic barriers. Pathfinder International used DHIS2 data to identify low-coverage local government areas and implemented targeted community outreach in collaboration with State Primary Health Care Development Boards, deploying trained vaccination teams alongside […]
Financing and Policy Dynamics in HPV Vaccine Uptake: Insights from Kenya’s Gavi Transition and Single-Dose Introduction
In Kenya, a retrospective analysis of HPV Dose 1 data from the national health information system (2019–2025) reveals a pronounced cyclical uptake pattern, with quarterly doses ranging from a low of 21,764 (Q1 2025) to a peak of 564,403 (Q4 2021), with surges consistently linked to intensified outreach campaigns and school calendar alignment and sharp […]
Using Geographic information System mapping for Evidence-Based Planning to Reach HPV vaccine Target Girls and Zero-Dose Children: Experience from Jigjiga Town, Ethiopia.
In Ethiopia, a 20-day house-to-house GIS mapping exercise conducted in Jigjiga town (Somali region) between August and September 2024 revealed major discrepancies between projected and actual target populations: official estimates placed the HPV-eligible girl population at 6,770, while the headcount identified 11,300 — a 67% undercount — and 14,935 girls were ultimately vaccinated, representing 132% […]